Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
5.77
+0.09 (1.58%)
Mar 2, 2026, 11:14 AM EST - Market open
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Foghorn Therapeutics stock have an average target of 11.71, with a low estimate of 9.00 and a high estimate of 13. The average target predicts an increase of 102.95% from the current stock price of 5.77.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Foghorn Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 6 | 6 | 6 |
| Buy | 3 | 3 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +107.97% | Feb 17, 2026 |
| BTIG | BTIG | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +90.64% | Dec 18, 2025 |
| Stifel | Stifel | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +107.97% | Dec 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +107.97% | Nov 7, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $9 | Buy | Reiterates | $9 | +55.98% | May 15, 2025 |
Financial Forecast
Revenue This Year
31.85M
from 22.60M
Increased by 40.91%
Revenue Next Year
35.63M
from 31.85M
Increased by 11.87%
EPS This Year
-1.13
from -1.58
EPS Next Year
-1.08
from -1.13
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 49.0M | 63.0M | ||||
| Avg | 31.8M | 35.6M | ||||
| Low | 24.0M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 116.8% | 97.8% | ||||
| Avg | 40.9% | 11.9% | ||||
| Low | 6.3% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.96 | -0.77 | ||||
| Avg | -1.13 | -1.08 | ||||
| Low | -1.28 | -1.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.